Clinical Trial Update: A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive [Phase 2]

View source ↗

Summary

Clinical trial update for INCB099280 in Phase 2 evaluating patients with select solid tumors who have not previously received immune checkpoint inhibitors; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• INCB099280 (INCB099280)

Snippet

Sponsor: Incyte Corporation | Conditions: Advanced Solid Tumor | Phase 2 | Status: ACTIVE_NOT_RECRUITING